Playfair Capital is an early-stage fund that invests in ambitious founders across various sectors.
Playfair Capital has backed the health technology firm in its latest funding round.
"It is fantastic to be working with the Playfair Capital team who share our vision of making cutting edge research accessible to all healthcare providers and their patients"
The seed round was led by Playfair Capital and will support product development and team expansion.
"Many people living with cancer feel isolated and unsupported, and traditional routes of delivering healthcare struggle to address these issues. It’s also imperative that we gather the necessary data to understand how cancer therapies affect not just survival, but quality of life, so that patients and doctors can weigh up this information to make informed decisions about their care. At Vine, our goal is to put patients back in control."
Amadeus Capital Partners led the seed round with participation from Global Brain Corporation, Techstars and existing investors.
"Machine learning is revolutionising every industry. It has become much easier to build predictive models but deploying and managing these models in production is the limiting factor."
